Category: Cancer Treatment
Cancer Treatment market research reports by GlobalData
-
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Se ... Read More
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
Bone Cancer - Global Clinical Trials Review, 2024
Bone Cancer - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Bone Cancer - Global Clinical Trials Review, 2024 provides an overview of Bone Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Cancer. Report inc ... Read More
-
Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024
Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2024 provides an overview of Muscle Invasive Bladder Cancer (MIBC) Clinical trials scenario. This report pro ... Read More
-
Soft Tissue Sarcoma: Competitive Landscape
Soft Tissue Sarcoma: Competitive Landscape Soft Tissue Sarcoma: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in soft tissue sarcoma therapeutics. In 2024, more than 300,000 diagnosed prevalent cases of STS are anticipated ... Read More
-
HER2-Positive Breast Cancer: Epidemiology Forecast to 2033
HER2-Positive Breast Cancer: Epidemiology Forecast to 2033 Summary Breast cancer (International Classification of Diseases, 10th Revision [ICD-10] codes C50.0-50.9) is a malignant tumor that originates in the breast tissue. Breast cancer cells begin inside the milk ducts of the breast. The earliest ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 provides an overview of Chronic Lymphocytic Leukemia (CLL) Clinical trials scenario. This report provides top ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
Mycosis Fungoides - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mycosis Fungoides - Global Clinical Trials Review, 2024 provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical trials on Mycos ... Read More
-
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024 provide ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
Ewing Sarcoma - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, 2024 provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Re ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024 provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This r ... Read More
-
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More
-
Thematic Intelligence - Biosimilars in oncology
Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More
-
Anal Cancer (AC) - Competitive Landscape
Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More
-
Digital Marketing Trends in Non-small Cell Lung Cancer
Digital Marketing Trends in Non-small Cell Lung Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across non-small cell lung cancer (NSCLC) patient sites in the US, with over 2.4 million visitors from October 2022 to September 2023. This was followed by BMS's Opdivo.com (1.7 mil ... Read More
-
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory ... Read More
-
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Trial ... Read More
-
Digital Marketing Trends in Colorectal Cancer
Digital Marketing Trends in Colorectal Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across CRC patient sites in the US, with over 3.3 million visitors from August 2022 to July 2023. This was followed by BMS’s Opdivo.com (1.7 million visits) and Roche’s Avastin.com (258,000 ... Read More
-
Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030
Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Speech Aid Devices Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Speech Aid Devices Procedures. The databook report provides ... Read More
Research Assistance
